258 related articles for article (PubMed ID: 24135717)
1. Immune surveillance of unhealthy cells by natural killer cells.
Iannello A; Raulet DH
Cold Spring Harb Symp Quant Biol; 2013; 78():249-57. PubMed ID: 24135717
[TBL] [Abstract][Full Text] [Related]
2. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells.
Iannello A; Thompson TW; Ardolino M; Lowe SW; Raulet DH
J Exp Med; 2013 Sep; 210(10):2057-69. PubMed ID: 24043758
[TBL] [Abstract][Full Text] [Related]
3. NKG2D Ligand Shedding in Response to Stress: Role of ADAM10.
Zingoni A; Vulpis E; Loconte L; Santoni A
Front Immunol; 2020; 11():447. PubMed ID: 32269567
[TBL] [Abstract][Full Text] [Related]
4. NKG2D ligands mediate immunosurveillance of senescent cells.
Sagiv A; Burton DG; Moshayev Z; Vadai E; Wensveen F; Ben-Dor S; Golani O; Polic B; Krizhanovsky V
Aging (Albany NY); 2016 Feb; 8(2):328-44. PubMed ID: 26878797
[TBL] [Abstract][Full Text] [Related]
5. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
[TBL] [Abstract][Full Text] [Related]
6. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D
Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194
[TBL] [Abstract][Full Text] [Related]
7. "Acquired" NKG2D Ligand Stimulates NK Cell-mediated Tumor Immunosurveillance.
Wang D; Gu X; Liu X; Liu X; Wang B; Lao F; Fang M
J Immunother; 2019; 42(6):189-196. PubMed ID: 31145234
[TBL] [Abstract][Full Text] [Related]
8. Regulation of ligands for the NKG2D activating receptor.
Raulet DH; Gasser S; Gowen BG; Deng W; Jung H
Annu Rev Immunol; 2013; 31():413-41. PubMed ID: 23298206
[TBL] [Abstract][Full Text] [Related]
9. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
Teng MW; Kershaw MH; Hayakawa Y; Cerutti L; Jane SM; Darcy PK; Smyth MJ
J Biol Chem; 2005 Nov; 280(46):38235-41. PubMed ID: 16169855
[TBL] [Abstract][Full Text] [Related]
10. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
11. Innate immune recognition of double-stranded RNA triggers increased expression of NKG2D ligands after virus infection.
Esteso G; Guerra S; Valés-Gómez M; Reyburn HT
J Biol Chem; 2017 Dec; 292(50):20472-20480. PubMed ID: 28986447
[TBL] [Abstract][Full Text] [Related]
12. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
Front Immunol; 2020; 11():40. PubMed ID: 32082316
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated cellular functions and cell stress pathways provide critical cues for activating and targeting natural killer cells to transformed and infected cells.
Raulet DH; Marcus A; Coscoy L
Immunol Rev; 2017 Nov; 280(1):93-101. PubMed ID: 29027233
[TBL] [Abstract][Full Text] [Related]
14. NKG2D and cytotoxic effector function in tumor immune surveillance.
Hayakawa Y; Smyth MJ
Semin Immunol; 2006 Jun; 18(3):176-85. PubMed ID: 16675266
[TBL] [Abstract][Full Text] [Related]
15. NKG2D Receptor and Its Ligands in Host Defense.
Lanier LL
Cancer Immunol Res; 2015 Jun; 3(6):575-82. PubMed ID: 26041808
[TBL] [Abstract][Full Text] [Related]
16. Tumoral NKG2D alters cell cycle of acute myeloid leukemic cells and reduces NK cell-mediated immune surveillance.
Tang M; Acheampong DO; Wang Y; Xie W; Wang M; Zhang J
Immunol Res; 2016 Jun; 64(3):754-64. PubMed ID: 26740330
[TBL] [Abstract][Full Text] [Related]
17. NKG2D and its ligands.
Obeidy P; Sharland AF
Int J Biochem Cell Biol; 2009 Dec; 41(12):2364-7. PubMed ID: 19631280
[TBL] [Abstract][Full Text] [Related]
18. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
19. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
[TBL] [Abstract][Full Text] [Related]
20. NKG2D and its ligands in cancer.
Dhar P; Wu JD
Curr Opin Immunol; 2018 Apr; 51():55-61. PubMed ID: 29525346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
